There are 2789 resources available
485P - A phase Ib study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: The preliminary result of CEFRU study
Presenter: YONG LI
Session: ePoster Display
486P - Bioavailability and activity of oncolytic virus TG6002 after intravenous administration in patients with advanced gastrointestinal carcinomas
Presenter: Philippe A. Cassier
Session: ePoster Display
464P - Exome sequencing of ctDNA portrays the mutational landscape of patients with relapsing colon cancer and indicates new actionable targets
Presenter: Noelia Tarazona
Session: ePoster Display
465P - Identification of actionable alterations in primary colorectal tumors using NGS-based comprehensive genomic profiling
Presenter: Alfred KY Lam
Session: ePoster Display
466P - Landscape of HER2 alterations in 5786 Chinese patients with colorectal cancer
Presenter: Xiaoyun Li
Session: ePoster Display
467P - Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial
Presenter: Eleonora Lai
Session: ePoster Display
468P - Prognostic role of aspartate aminotransferase-to-alanine aminotransferase ratio and lactate dehydrogenase levels in resectable colorectal cancer
Presenter: Ma Yifei
Session: ePoster Display
469P - Potential emergent role of liquid biopsy in clinical practice in metastatic colorectal cancer (mCRC) treatment
Presenter: Valeria Zurlo
Session: ePoster Display
Resources:
Abstract
470P - Genomic landscape and its correlations with immunotherapy-related biomarkers in Chinese colorectal cancer patients
Presenter: Xiao Zheng
Session: ePoster Display
Resources:
Abstract